Pricing updated 2019-04-24. Prices are subject to change without notice.
CCT251545 is an orally bioavailable inhibitor of Wnt signaling (IC50 = 5 nM).1 It is a potent and selective inhibitor of the human mediator complex-associated protein kinases Cdk8 and Cdk19.2 Through its effects on Cdk8 and Cdk19, CCT251545 alters Wnt pathway-regulated gene expression.2 It reduces tumor growth in COLO 205 human colon cancer xenografts after oral dosing (70 mg/kg bid) and in Wnt-dependent tumors.1,2
Warning - this product is not for human or veterinary use.
View the Cayman Structure Database for chemical structure definitions for many Cayman products
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.
Mallinger, A., Crumpler, S., Pichowicz, M., et al. Discovery of potent, orally bioavailable, small-
2. Dale, T., Clarke, P.A., Esdar, C., et al. A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease Nat. Chem. Biol. 11(12), 973-980 (2015).